Is Pfizer's Discounted Valuation a Buying Opportunity or a Value Trap?

Is Pfizer's Discounted Valuation a Buying Opportunity or a Value Trap?  The Globe and Mail

Summary aggregated from The Globe and Mail's public RSS feed. The full reporting belongs to The Globe and Mail — please read it on their site.